First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa

Clinical Microbiology and Infection

Volumn 19, Issue 9, 2013, Pages

  Gilarranz, R ^a   Juan, C ^b   Castillo Vera, J ^b,c   Chamizo, F J ^a   Artiles, F ^a   Alamo I ^a   Oliver, A ^b  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Class B carbapenemases; Environmental reservoirs; Metallo lactamases; Pseudomonas putida; Transferable resistance determinants

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DNA 16S; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE IMP 15; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CYSTIC FIBROSIS; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; PULSED FIELD GEL ELECTROPHORESIS; SPAIN;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA;

EID: 84882591615     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12248     Document Type: Article

References (21)

1. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361: 2068-2077.
2. Lyczak JB, Cannon CL, Pier GB. Lung infection associated with cystic fibrosis. Clin Microbiol Rev 2002; 15: 194-222.
3. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34: 634-640.
4. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22: 582-610.
5. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-512.
6. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-281.
7. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-755.
8. Cabot G, Ocampo-Sosa AA, Domínguez MA et al. Genetic markers of widespread extensively drug-resistant (XDR) Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother 2012; 56: 6349-6357.
9. Juan C, Zamorano L, Mena A et al. Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother 2010; 65: 474-478.
10. Scotta C, Juan C, Cabot G et al. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-β-lactamases. Antimicrob Agents Chemother 2011; 55: 5376-5379.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Vol. 28, No 3, 18th informational supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
12. Senda K, Arakawa Y, Ichiyama S et al. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol 1996; 34: 2909-2913.
13. Gutiérrez O, Juan C, Cercenado E et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother 2007; 51: 4329-4335.
14. Samuelsen O, Toleman MA, Sundsfjord A et al. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 2010; 54: 346-352.
15. García-Castillo M, Del Campo R, Morosini MI et al. Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol 2011; 49: 2905-2910.
16. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001; 45: 105-116.
17. Aubron C, Poirel L, Ash RJ et al. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg Infect Dis 2005; 11: 260-264.
18. Martin CA, Morita K, Ribes JA et al. IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico. Antimicrob Agents Chemother 2008; 52: 2289-2290.
19. Garza-Ramos U, Morfin-Otero R, Sader HS et al. Metallo-β-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother 2008; 52: 2943-2946.
20. Garza-Ramos JU, Sanchez-Martinez G, Barajas JM et al. Variability of the bla(IMP-15)-containing integrons, highly related to In95, on an endemic clone of Pseudomonas aeruginosa in Mexico. Microb Drug Resist 2010; 16: 191-195.
21. Quinones-Falconi F, Galicia-Velasco M, Marchiaro P et al. Emergence of Pseudomonas aeruginosa strains producing metallo-β-lactamases of the IMP-15 and VIM-2 types in Mexico. Clin Microbiol Infect 2010; 16: 126-131.